INC Research, Inc. Completes Acquisition of Global Clinical Development Unit of MDS Pharma Services

Published: Jul 01, 2009

RALEIGH, N.C.--(BUSINESS WIRE)--INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced it has completed the acquisition of the Phase II-IV operations (Global Clinical Development) of MDS Pharma Services, a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ).

Back to news